At the 2016 National NET Patient Conference, Laughter is the BEST Medicine!

Looking for a few laughs on Friday night at the National NET Patient Conference?

NCAN is so excited to finally announce the Friday night social event sponsored by NCAN for the 2016 National NET Patient Conference taking place in just a few weeks! This is a great time to network and relax, taking a break from all the heavy information that will be introduced over this amazing, jam packed weekend!

Introducing Emmy Award winning writer, speaker, comedian and fellow cancer survior Steve Mazan:

stevemazan

Come enjoy a hysterically funny show- ‘Laughter is the Best Medicine’- just for attendees of the 2016 National Neuroendocrine Cancer Patient Conference, starring Emmy Award winning writer, speaker, comedian and fellow neuroendocrine cancer survivor Steve Mazan. Steve is known for his Emmy Award winning writing for The Ellen DeGeneres Show and for performing his comedy on The Late Show with David Letterman, BUT he is most well known for his award winning film, ‘Dying to Do Letterman.’ 

Steve will be hanging out with the crowd, signing autographs, and he will have some merchandise to give away! There will also be a raffle where you can win an autographed DVD of one of Steve’s best shows!

On your way to the show, from 5 pm to 6:15 pm, stop for some healthy and delicious smoothies and cookies provided by one of the conferences sponsors. These tasty treats were designed specifically with neuroendocrine cancer patients in mind. Doors to the show will open at 6 pm and light refreshments will be served. At 7, it’s time for the show, sponsored by the Neuroendocrine Cancer Awareness Network! 

It’s all happening right in the same hall as Friday’s General Session so it’s easy to get to. This is a great time to network and relax, taking a break from all the heavy information that will be introduced over this amazing, jam packed weekend!

Want to learn more about Steve? Visit SteveMazan.com or check out DyingtoDoLetterman.com for more information on Steve Mazan, his cancer journey, and to check out Dying to Do Letterman. Also, check out this Ted Talks that Steve Mazan did back in 2011: It’s Never too Late to Live your Dreams.

For more information on the 2016 National NET Patient Conference in New Orleans, LA September 22nd, 2016 to September 24th, 2016, please click here!

NCAN Bandaid

Speaker Spotlight – National Conference Edition Part 11

drhowe

James R. Howe V, MD

uofiowaclinic

Bio:

Director, Division of Surgical Oncology and Endocrine Surgery

Co-Director, Neuroendocrine Cancer Clinic

Professor of Surgery  – Surgical Oncology and Endocrine Surgery

Education:

MD, University of Vermont College of Medicine

Fellowship, Surgical Research Fellow, Washington University

Residency, General Surgery, Barnes Hospital

Fellowship, Clinical, Surgical Oncology, Memorial Sloan-Kettering Center

Licensure and Certifications:

Iowa Medical License, Iowa Board of Medicine

Certified, Advanced Trauma Life Support

Board Certified, General Surgery, American Board of Surgery

Qualifying Examination, American Board of Surgery

Recertification Examination, American Board of Surgery

Research Summary:

I am a Surgical Oncologist and Endocrine Surgeon who specializes in taking care of patients with cancers of the pancreas, liver, GI tract, soft tissue sarcoma, melanoma, thyroid, parathyroid, and adrenal glands; I am co-director of the neuroendocrine cancer clinic, Division Director of Surgical Oncology and Endocrine Surgery, and Professor of Surgery at the University of Iowa. My area of research expertise is in Familial Cancer Syndromes, genetic linkage, gene discovery, and gene expression studies. My postdoctoral training at Washington University under Helen Donis-Keller, Ph.D. and Samuel Wells, M.D., was directed at the identification of the gene for Multiple Endocrine Neoplasia Type 2. As a faculty member, my focus has been the genetics of Juvenile Polyposis, which led to the discovery of the 2 predisposing genes. More recently, I have developed a large clinical practice and research interest in the genetics of neuroendocrine tumors (NETs). Our current research focus is the study of gene expression profiles in pancreatic and small bowel NETs to identify new targets for imaging and treatment, and collection of families to search for predisposing genes.

For more information on Dr. James Howe and the University of Iowa Hospitals and Clinics, please visit their website here. You can also view Dr. Howe’s academic profile, here.

You can read Dr. Howe’s publications by clicking here.

For information on the Neuroendocrine Cancer Program at the University of Iowa Hospitals and Clinics, you can find that here.

To make an appointment, please contact:

University of Iowa Hospitals and Clinics: 200 Hawkins Drive, Iowa City, IA 52242

Phone: (800) 777-8442 or (319) 356-1727

Dr. Howe at the 2016 National NET Patient Conference:

Topic: Hepatic Resection vs Liver Directed Therapy

When: Saturday, September 24th, 2016 at 8:30AM*

SIGN UP NOW FOR THE 2016 NATIONAL NET PATIENT CONFERENCE in New Orleans, LA from September 22-24th to see Dr. Howe and 19 other experts speak on Neuroendocrine Cancer! 

Registration is $125 per person including

  • Thursday’s Welcome Reception 
  • Breakfast, Lunch, and snacks for both Friday and Saturday
  • And keep your eyes out for some special prizes!

Registration does not include your hotel stay or travel expenses.

For more information and to buy your ticket, click here!!

*Time and Date are subject to change.

To check out some of our other speakers, click here!

Speaker Spotlight – National Conference Edition Part 10

drheidiconnolly

Heidi M. Connolly, M.D.

mayoclinic

Location

  • Minnesota

Departments

  • Cardiovascular Diseases

Education

  • Fellow – Adult Congenital Heart Disease Special Fellowship
    Mayo Graduate School of Medicine, Mayo Clinic College of Medicine
  • Fellow – Cardiovascular Diseases
    Mayo Graduate School of Medicine, Mayo Clinic College of Medicine
  • Resident – Internal Medicine
    Mayo Graduate School of Medicine, Mayo Clinic College of Medicine
  • MD
    Royal College of Surgeons in Ireland
  • Other – Undergraduate
    Hamline University

Certifications

  • Cardiovascular Diseases
  • Internal Medicine

Academic rank

  • Professor of Medicine

Professional Highlights

  • Director, Adult Congenital Heart Disease Clinic
  • Director, Congenital Heart Center

Interests

  • Adult congenital heart disease
  • Carcinoid heart disease
  • Echocardiography
  • Marfan syndrome and other aortic disorders
  • Pregnancy and heart disease

For more information on Dr. Heidi Connolly and the Mayo Clinic in Rochester, MN, please visit their website here and the US News report on her here.

You can read Dr. Connolly’s publications by clicking here.

To make an appointment, please contact:

Mayo Clinic Rochester: 200 1st Street SW, Rochester, MN 55905

Phone: (507) 284-2511 or (507) 538-3270

Dr. Connolly at the 2016 National NET Patient Conference:

Topic: Carcinoid Heart Disease: What you need to know

When: Saturday, September 24th, 2016 at 8:00AM*

SIGN UP NOW FOR THE 2016 NATIONAL NET PATIENT CONFERENCE in New Orleans, LA from September 22-24th to see Dr. Connolly and 19 other experts speak on Neuroendocrine Cancer! 

Registration is $125 per person including

  • Thursday’s Welcome Reception 
  • Breakfast, Lunch, and snacks for both Friday and Saturday
  • And keep your eyes out for some special prizes!

Registration does not include your hotel stay or travel expenses.

For more information and to buy your ticket, click here!!

*Time and Date are subject to change.

To check out some of our other speakers, click here!

Speaker Spotlight – 2016 National Conference Edition Part 9

drwoltering

Eugene A. Woltering, MD, FACS

Bio:

Eugene A. Woltering, M.D .FACS,is the James D. Rives Professor of Surgery and Neurosciences at the Louisiana State University Health Sciences Center in New Orleans. He also is the Section Chief of Surgical Endocrinology and the Director of Surgical Research at this institution. Dr. Woltering attended medical school at Ohio State University School of Medicine and completed his surgical residency at Vanderbilt University Affiliated Hospitals in Nashville, Tennessee. Dr. Woltering has also completed fellowships in surgical oncology at The OhioState University School of Medicine and the National Cancer Institute. Dr. Woltering specializes in the diagnosis and management of neuroendocrine tumors of the gastroenteropancreatic tract. His research interests include the development of radioactive drugs for the diagnosis and therapy of tumors and the development of human tissue based models that can be used to product drug activity in patients.

To make an appointment, please contact Pam Ryan, RN:

NOLANETS-New Orleans Louisiana Neuroendocrine Tumor Specialists                  200 West Esplanade, Ste. 200                                                                                        Kenner, LA 70065                                                                                                                    (504) 464-8500                                                                                                                               or toll free: (866) 91-ZEBRA

For more information about Dr. Woltering, please visit Oschner Health Center’s website here or his LSU profile here.

For more information on Dr. Gene Woltering and NOLA NETs, please visit their website here.

Dr. Woltering at the 2016 National NET Patient Conference:

Topic: Biomarkers: The Emerging Role of Pancreastatin and Neurokinin A

When: Friday, September 23th, 2016 at 9:45AM*

SIGN UP NOW FOR THE 2016 NATIONAL NET PATIENT CONFERENCE in New Orleans, LA from September 22-24th to see Dr. Woltering and 19 other experts speak on Neuroendocrine Cancer! 

Registration is $125 per person including

  • Thursday’s Welcome Reception 
  • Breakfast, Lunch, and snacks for both Friday and Saturday
  • And keep your eyes out for some special prizes!

Registration does not include your hotel stay or travel expenses.

For more information and to buy your ticket, click here!!

*Time and Date are subject to change.

To check out some of our other speakers, click here!

Speaker Spotlight – 2016 National Conference Edition Part 8

drtang

Laura H. Tang, MD, PhD

Pathologist

sloanketteringcc

Bio:

I am a pathologist who is trained in gastrointestinal surgical pathology and as a basic scientist with a focus on molecular pathophysiology of the gastrointestinal tract. My primary specialty is digestive diseases, particularly cancers of the gastrointestinal tract and the pancreas. I also specialize in gastroesophageal reflux disease (GERD) and Barrett’s esophagus, and have a special interest in gastrointestinal neuroendocrine tumors and carcinoid disease.

My investigative research involves elucidating the molecular mechanisms of cell proliferation and the regulation of malignant cell transformation, both with the goal of developing molecular techniques that will improve the early diagnosis and treatment of gastrointestinal tract cancers. I am currently involved in a multidisciplinary investigation of Barrett’s-related dysplasia and esophageal cancer. My career goals are to maintain excellence in the area of surgical pathology and diagnosis, and to improve patient care by developing strategies to speed the evolution of the field of morphologic pathology into a new era of functional and molecular pathology.

For more information on Dr. Laura Tang and Memorial Sloan Kettering Cancer Center, please visit their website here.

You can read Dr. Tang’s journal articles by clicking here.

Dr. Tang at the 2016 National NET Patient Conference:

Topic: The Histology Staging & Grading of NETs

When: Friday, September 23th, 2016 at 8:45AM*

SIGN UP NOW FOR THE 2016 NATIONAL NET PATIENT CONFERENCE in New Orleans, LA from September 22-24th to see Dr. Tang and 19 other experts speak on Neuroendocrine Cancer! 

Registration is $125 per person including

  • Thursday’s Welcome Reception 
  • Breakfast, Lunch, and snacks for both Friday and Saturday
  • And keep your eyes out for some special prizes!

Registration does not include your hotel stay or travel expenses.

For more information and to buy your ticket, click here!!

*Time and Date are subject to change.

To check out some of our other speakers, click here!

Speaker Spotlight – 2016 National Conference Edition Part 7

drmetz

David C. Metz, MD

Professor of Medicine
Division of Gastroenterology
Hospital of University of Pennsylvania
Philadelphia, PA

pennmedicine

Bio:

Dr Metz is Professor of Medicine and Associate Chief for Clinical Affairs in the Division of Gastroenterology at the University of Pennsylvania in Philadelphia, where he is director of the Acid-Peptic Disease Program and codirector of the GI Physiology Laboratory, the Swallowing Disorders Program and the Neuroendocrine Tumor Program.

He is actively involved in clinical research, patient care, and teaching of students, residents, and fellows. Dr Metz’s clinical research program is particularly active in acid-peptic conditions including hypersecretory states such as Zollinger-Ellison syndrome, Helicobacter pylori infection, nonsteroidal anti-inflammatory drug gastropathy, and gastroesophageal reflux disease. He also has particular expertise in the diagnosis and management of patients with functional and non-functional neuroendocrine tumors of the pancreas and alimentary tract. He has been a principal investigator on a number of trials evaluating upper gastrointestinal disease states. He is also active in national gastroenterology societies and was a prior member of the Liason Committee for Recertification of the American Board of Internal Medicine (American Gastroenterological Association representative) and the US Food and Drug Administration Gastrointestinal Drugs Advisory Committee. He is vice chair of the North American Neuroendocrine Tumor Society (NANETS)

Dr Metz earned his MBBCh (MD equivalent) from the University of the Witwatersrand in Johannesburg, South Africa. He moved to the United States in 1986 and pursued a residency in internal medicine at Albert Einstein Medical Center in Philadelphia. He completed a fellowship in gastroenterology in Washington, DC, in the combined Georgetown/Veterans Affairs Medical Center/National Institutes of Health (NIH) program. He remained on staff at the NIH for 2 more years as a senior staff fellow, performing basic research in pancreatic acinar cell secretion and clinical research in Zollinger-Ellison syndrome specifically.

In 1993, Dr Metz moved to Philadelphia in the role of Assistant Professor in the clinician educator track at the University of Pennsylvania. He was promoted to Associate Professor in 1998 and Full Professor in 2003.

To make an appointment, please contact:

Bonnie Bennett at (215) 349-5562

Perelman Center for Advanced Medicine                                                                        South Pavilion, 4th Floor                                                                                                        3400 Civic Center Boulevard                                                                                 Philadelphia, PA 19104                                                                                                            (800) 789-PENN (7366)

For more information on Dr. David Metz and Penn Medicine at the University of Pennsylvania, please visit their website here.

Dr. Metz at the 2016 National NET Patient Conference:

Topic: The Role of the Gastroenterologist in Diagnosing and Treating NETs

When: Friday, September 23th, 2016 at 10:15AM*

SIGN UP NOW FOR THE 2016 NATIONAL NET PATIENT CONFERENCE in New Orleans, LA from September 22-24th to see Dr. Metz and 19 other experts speak on Neuroendocrine Cancer! 

Registration is $125 per person including

  • Thursday’s Welcome Reception 
  • Breakfast, Lunch, and snacks for both Friday and Saturday
  • And keep your eyes out for some special prizes!

Registration does not include your hotel stay or travel expenses.

For more information and to buy your ticket, click here!!

*Time and Date are subject to change.

To check out some of our other speakers, click here!

The Speaker Spotlight – 2016 National Conference Edition Part 6

liu

Eric Liu, MD, FACS Surgeon

RockyMountainCClogo

Bio:

DEGREES & EDUCATION:

Harvard University, Cambridge, MA, AB, 1992-1996, Biochemistry

Columbia University, College of Physicians & Surgeons, New York, NY, MD, 1996-2000

Columbia University, Research Fellowship, Mark Hardy, M.D., Islet Transplantation, 2000-2001

New York-Presbyterian Hospital, New York, NY, Residency in General Surgery, 2001-2004, 2007-2009

National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDK), National Institutes of Health, Senior Clinical Research Fellow, Islet/Autoimmunity Branch, David Harlan, 2004-2007.

Uppsala University, Uppsala, Sweden, Fellowship in Neuroendocrine Oncology, Kjell Oberg, 2009.

Vanderbilt University, Master of Science Clinical Investigation, 2013.

Dr. Liu serves as the Chief Medical Advisor for Healing NET Foundation, a 501(c)(3) dedicated to providing education about neuroendocrine cancers to the medical community, and supporting the best possible care for neuroendocrine patients.

HealingNET (3)

 

BOARD CERTIFICATIONS:

General Surgery

PATIENT CARE PHILOSOPHY:

“My focus is to always treat the patient – not just the disease.  I’ve told people many times that I value quality of life as highly as the quantity of life.  Therefore, I use every resource at my disposal to address the problems.  When treating neuroendocrine cancer, it is absolutely imperative to approach it with a multi-disciplinary approach because it crosses into so many different medical subspecialties.  When we are successful, these people can live good, healthy lives.  I find that giving the patient time and respect are critical to developing a sense of trust, because it is a team effort with the patient in the center.  Our goal at the Rocky Mountain Cancer Center is to build a home for neuroendocrine patients, where they can feel comfortable that everyone has experience in this rare disease and all their questions can be answered.  By having the most advanced expertise, imaging techniques, clinical trials, and treatments available all in one center, we can provide patients with the best hope for a healthy life.”

You can read Dr. Liu’s story on the Healing NET Foundation’s blog, here!

To make an appointment, please call:

Rocky Mountain Cancer Centers: Denver – Midtown                                                    1800 Williams Street                                                                                                               Suite 200                                                                                                                              Denver, CO 80218                                                                                                                     (303) 388-4876

For more information on Dr. Eric Liu and the Rocky Mountain Cancer Centers, please visit their website here.

Dr. Liu at the 2016 National NET Patient Conference:

Topic: Somatostatin Analogs: Which SSA to Choose

When: Saturday, September 24th, 2016 at 2PM*

SIGN UP NOW FOR THE 2016 NATIONAL NET PATIENT CONFERENCE in New Orleans, LA from September 22-24th to see Dr. Liu and 19 other experts speak on Neuroendocrine Cancer! 

Registration is $125 per person including

  • Thursday’s Welcome Reception 
  • Breakfast, Lunch, and snacks for both Friday and Saturday
  • And keep your eyes out for some special prizes!

Registration does not include your hotel stay or travel expenses.

For more information and to buy your ticket, click here!!

*Time and Date are subject to change.

You can also see Dr. Liu speak at the 2016 LungNET Conference on Saturday, June 11th, 2016 in Denver, CO!!

Registration for the 2016 LungNET Conference is $25 per person and includes breakfast, lunch, and snacks!

Registration does not include your hotel stay or travel expenses.

For more information and to buy your ticket to the 2016 LungNET Conference, click here!

Dr. Liu will have extended clinic hours for Wednesday, June 8th through Friday, June 10th. Please book these ASAP as they are also extremely limited and WILL fill up! If you would like to make an appointment, please call (303) 388-4876.

Want the chance to see BOTH amazing conferences? Sign up NOW to get FREE registration for the 2016 LungNET Conference when you register for the 2016 National NET Patient Conference. SEE HOW TO GET FREE REGISTRATION TO THE 2016 LUNGNET CONFERENCE!

The Speaker Spotlight – LungNET Conference 2016

NCAN Bandaid

HealingNET (3)

As many of you know, NCAN in partnership with The Healing NET Foundation have a LungNET specific conference coming up on Saturday, June 11th, 2016 in Denver, CO. I wanted to take this opportunity to introduce you guys to the great speakers that are lined up, including Dr. Kjell Öberg from Uppsala, Sweden!

drramirez

So far, I have introduced you to Dr. Robert Ramirez, if you missed my post on him, be sure to check that out here.

drkornbluth

Craig Kornbluth, M.D.

Bio:

Dr. Craig Kornbluth is a Board Certified Radiologist specializing in Body Imaging.  He completed his undergraduate degree at Yeshiva University in New York, NY and obtained his doctorate from FUHS/The Chicago School of Medicine, in N. Chicago, IL. Dr. Kornbluth completed his Diagnostic Radiology residency at St. Luke/Roosevelt Hospital New York, NY  followed by a Body imaging fellowship at Johns Hopkins Medical Center in Baltimore, MD.

Dr. Kornbluth is a leader in the Denver Medical Community and has been named multiple times on the Top Doctor list in 5280 Magazine.  He has been involved in multiple research projects and lectures across the country on imaging specifically of the Abdomen and pelvis.

Dr. Kornbluth resides with his family in Denver, Colorado.  When Dr. Kornbluth is not working, he spends his time hiking, fly-fishing, biking, golfing and snowboarding in the beautiful Rocky Mountains.

You can find Dr. Kornbluth at Diversified Radiology in Lakewood, CO.

drryan

Margaret Ryan, M.D.

Bio:

Dr. Margaret Ryan has a medical practice in Denver CO. Dr. Ryan specializes in pathology, and has over 8 years of experience in the field of medicine. She graduated from Ohio State University College Of Medicine with her medical degree in 2008. She is affiliated with numerous hospitals in the Denver area including Hca Healthone Llc and more. Dr. Ryan is accepting new patients at her medical office and practice location in Denver, Colorado. She is available for appointments, preventative care, medical care as well as ongoing patient care.

drparker

Richard Parker, M.D.

Bio:

Dr. Richard Parker is board-certified in general, thoracic and cardiovascular surgery. He serves patients at Presbyterian/St. Luke Medical Center and Rose Medical Center. He completed his fellowship in thoracic and cardiovascular surgery at the University of Colorado and his postgraduate fellowship in cardiovascular surgery from Mayo Graduate School of Medicine.

Prior to joining HealthONE, he served as a physician at Colorado Cardiovascular Surgical Associates. Currently, he serves as Chief of Cardiovascular Surgery at Rose Medical Center and Chairman of the Department of Cardiovascular Surgery at Presbyterian/St. Luke Medical Center. He has co-authored several papers and presented research at well-known seminars and conferences.

Dr. Richard Parker is experienced in all aspects of thoracic (heart, lung, esophageal and chest wall) surgery, coronary artery surgery and has been a pioneer in minimal access VATS surgery of the chest. He also has extensive experience in aortic and mitral valve surgery, including the minimal access approach.

For the past 20 years, he has been named one of 5280 magazine’s “Best Doctors”.

For more information on Dr. Parker, you can click here.

drkobitary

Majd Kobitary, M.D., F.C.C.P.

Bio:

Dr. Kobitary is board-certified in Pulmonary Medicine and Critical Care Medicine. He earned his medical degree from Damascus University Medical School. He completed Internal Medicine Residency at St. Francis Hospital in Evanston in Illinois and Pulmonary and Critical Care Fellowship at the University of Wisconsin. He completed an additional fellowship in Interventional Pulmonology from the University of Iowa. He has experience in advanced bronchoscopic procedures such as stenting and laser therapy for tumor removal.

For more information on Dr. Kobitary, click here.

droberg

Kjell Öberg, M.D.

Bio:

Dr. Kjell Öberg is Professor of Endocrine Oncology at the Medical Faculty of Uppsala University. He was the former head of the Department of Endocrine Oncology, University Hospital, and he is a specialist in endocrinology and internal medicine. He founded the Dept. of Endocrine Oncology at Uppsala University Hospital and has 30 years experience in the field of neuroendocrine tumors. Between 1986 and 1992 he was clinical associate director of the Ludwig Institute for Cancer Research. From 1998 to 2002 he was chairman of the Department of Medical Sciences at the Medical Faculty of Uppsala University. Since July 2002 until June 2008 he has been the Dean of the Medical Faculty. He is the chairman of Centre of Excellence of Endocrine Tumors and Vice chairman of the Department of Endocrine Oncology, University Hospital, Uppsala. Currently Adjunct Professor of Surgery at Vanderbilt University, Nashville, US.

Dr. Öberg was one of the founders and coordinator of the European Neuroendocrine Tumor Network (ENET) 1995-2000 and was past chairman of the Nordic Neuroendocrine Tumour Group. He has pioneered the treatment of carcinoid tumor patients with interferon and somatostatin analogues and developed assays for tumor markers such as Chromogranin A and radiological procedures including specialized PET scans.

In 1988 he was the first to describe a genetic deletion in multiple endocrine neoplasia Type 1 (MEN1). Dr Öberg has given many hundreds of presentations at international meetings and published more than 500 papers within his research field, H-factor 64 and more than 12,000 citations. In addition he is the author of numerous chapters on Carcinoid tumors in several international textbooks including William’s Textbook of Endocrinology, Leslie de Groot’s Textbook of Endocrinology, Clinical Endocrinology and Fordtran’s Textbook of Gastroenterology. Dr. Öberg is Editor-in Chief of World Journal of Gastroenterolgy (WJG).

In 1991 Dr. Öberg received the European Interferon Research reward. In 2003 he received the award “Eminent Scientist Year 2003” by the International Research Promotion Council (IRPC) and World Scientist Forum and in 2004 he was awarded the European Gold Medal in Endocrinology from the English Endocrine Society. In November 2006 he received the Harry Boström Award Lecture at Swedish Medical Society. The University Hospital Clinical Research Award in 2011.

Dr. Öberg is a member of the Royal Society of Sciences, member of Swedish Society of Medical Research, Honorary member of Finnish Oncology Society, Finnish Endocrine Society and Honorary member of Spanish Neuroendocrine NET-work. Dr. Öberg is Chairman Elect of ENETS and also a member of NANETS Advisory Board as well as several other national and international research and scientific boards and many scientific journal review boards.

For more on Dr. Öberg, click here.

drcohn

Allen Cohn, M.D.

Bio:

Dr. Allen Cohn is a medical oncologist in Denver, Colorado. He received his medical degree from University of Maryland School of Medicine and has been in practice for more than 20 years. Dr. Cohn’s specialties include Gastrointestinal Cancer, Carcinoid/Neuroendocrine Tumors (NET) and Neurological Oncology.

For more information on Dr. Cohn, click here.

drnutting

Charles Nutting, D.O., F.S.I.R.

Bio:

Dr. Nutting completed his undergraduate education at Loyola University of Chicago and graduated from Chicago College of Osteopathic Medicine in 1992. He did his residency and internship in Diagnostic Radiology at Olympia Fields Hospital and Medical Center in Chicago, IL.  Charles Nutting completed his fellowship in Interventional Radiology at Rush-Presbyterian-St. Luke’s Medical Center in Chicago.  Charles Nutting then practiced at Resurrection Medical Center in Chicago. In addition, Dr. Nutting practiced in Phoenix where he held positions at Phoenix Children’s Hospital, St. Joseph’s Hospital and Medical Center, and served as the Chief of Interventional Radiology at Good Samaritan Regional Medical Center. Dr. Nutting joined Radiology Imaging Associates (RIA) in November of 2004. 

Dr. Nutting is a board-certified, fellowship-trained interventional radiologist specializing in performing minimally invasive image-guided procedures to treat liver cancer and vein disorders.  He has the distinction of being a Fellow of the Society of Interventional Radiology (FSIR). Charles Nutting practices at RIA Endovascular where he does consultations for innovative liver cancer therapies.

Charles Nutting offers leading-edge procedures including chemoembolization, radiofrequency ablation and selective internal radiation therapy (SIRT). When not in the office, he treats endovascular disease, vein disorders and cancer in local and regional hospitals throughout the Rocky Mountain region. He is Chief of Interventional Radiology at Sky Ridge Medical Center.

Dr. Nutting was the first physician in the United States to do liver radioembolization with Sir-Sphere®. He has since performed more than 900 radioembolization procedures, and teaches this SIRT procedure using Y90 internal radiation beads nationwide.

To read more about Dr. Nutting, click here.

liu

Be on the lookout for our last profile on Dr. Eric Liu this Saturday!!

Registration for the 2016 LungNET Conference is $25 per person and includes breakfast, lunch, and snacks!

Registration does not include your hotel stay or travel expenses.

If you missed out on all the basic information about the 2016 LungNET Conference in Denver, CO on Saturday, June 11th, you can find that information here.

Click here to register for the 2016 LungNET Conference!

The Speaker Spotlight – 2016 National Conference Edition Part 5

O'Dorisio

Thomas O’Dorisio, MD

Professor of Medicine, Director of the Neuroendocrine Tumor Clinics Program

UIhosplogo

Bio:

Dr. Thomas O’Dorisio is Professor of Medicine and Director of the Neuroendocrine Tumor Clinics Program in the Holden Comprehensive Cancer Center at the University of Iowa.   Currently 1700 patients with carcinoid and familial/sporadic neuroendocrine tumors in both children and adults are registered via an IRB approved consent form.  With Co-directors Dr. James R. Howe (Endocrine surgeon) and Dr. M. Sue O’Dorisio (Pediatric Oncology), there are seven dedicated multi-disciplinary neuroendocrine tumor clinics weekly that include a neuroendocrine tumor clinic for the Veterans Administration Hospital.  Multi- diagnostic and therapeutic modalities for these patients include the highly sensitive and specific 68-Gallium – DOTATOC PET scan.  We are currently analyzing the safety and efficacy data of 200 subjects who have had this scan.  Therapeutic advances include the registration trial of LU-177 –DOTA-Octretoate therapy, a multi-international institution protocol for progressive midgut carcinoid tumors.  We anticipate the first peptide receptor radio-nuclide therapy (PRRNT) Phase II trial in the United States with Y90-DOTA-(tyr)-Octreotide within the next two months.  We see between 16 and 24 new neuroendocrine patients monthly, and have 900-1200 neuroendocrine patient visits per year. Our Clinical-Clinical Research Center is modeled after the 21 or so European NET Centers of Excellence, dedicated to this rare cancer with a prevalence in the United States of about 110,000 patients and an incidence since 1989 that has risen by 500%.

To see his official University of Iowa Heath Care video profile, please click here.

Education:

BS, Regis College, Denver, Colorado

MS, Anatomy, Creighton University, Omaha, Nebraska

MD, Creighton University, Omaha, Nebraska

Internship, Internal Medicine, Creighton University

Residency, Internal Medicine, The Ohio State University, Columbus, Ohio

Fellowship, Endocrinology, The Ohio State University, Columbus, Ohio

Licensure and Certifications:

Medical License, Iowa Board of Medicine

Certification, The College of American Pathologists (CAP) Ohio

Certification of Accreditation, Department of Health & Human Services Health Care Financing Administration (HCFA) CLIA Laboratory

Certification, American Board of Internal Medicine

To make an appointment as a NEW patient, please call:

The Holden Comprehensive Cancer Center at the University of Iowa                        (319) 356-4200 Option #3, Ask for Molly Becker

University of Iowa Hospitals and Clinics                                                                       200 Hawkins Drive                                                                                                                    Iowa City, IA 52242                                                                                                                 (800) 777-8442

Dr. O’Dorisio at the 2016 National NET Patient Conference:

Topic: PRRT Trials in America: What’s New?

When: Friday, September 23rd, 2016 at 1PM*

Be sure not to miss Dr. O’Dorisio speak! And don’t miss him on our panel answering your questions!!

For more information on Dr. O’Dorisio and the Holden Comprehensive Cancer Center at the University of Iowa, please visit their website here.

SIGN UP NOW FOR THE 2016 NATIONAL NET PATIENT CONFERENCE in New Orleans, LA from September 22-24th to see Dr. O’Dorisio and 19 other experts speak on Neuroendocrine Cancer! 

Registration is $125 per person including

  • Thursday’s Welcome Reception 
  • Breakfast, Lunch, and snacks for both Friday and Saturday
  • And keep your eyes out for some special prizes!

Registration does not include your hotel stay or travel expenses.

For more information and to buy your ticket, click here!!

*Time and Date are subject to change.

The Speaker Spotlight – 2016 National Conference Edition Part 4

Campeau

Richard J. Campeau, MD, FACNM

oschnermedcenterlogo

Bio:

Dr. Richard Campeau is a Clinical Professor of Radiology (Nuclear Medicine) and Internal Medicine (Cardiology) at LSU and Tulane University Health Sciences Centers. Dr. Campeau attended Medical School at LSU School of Medicine. He then completed his internship and residency at Tulane University Health Sciences Centers followed by a fellowship in Nuclear Medicine at Johns Hopkins Hospital in Maryland. Currently, Dr. Campeau is the immediate past President (2007-2008) of the American College of Nuclear Medicine, and is a past President of the Southwest Chapter, Society of Nuclear Medicine. 

Dr. Campeau specializes in I-131 MIBG treatment.

To make an appointment, please contact Pam Ryan, RN:

NOLANETS-New Orleans Louisiana Neuroendocrine Tumor Specialists                  200 West Esplanade, Ste. 200                                                                                        Kenner, LA 70065                                                                                                                    (504) 464-8500                                                                                                                               or toll free: (866) 91-ZEBRA

For more information on the NOLANETS Group and Dr. Richard Campeau, please visit their website here.

Dr. Campeau at the 2016 National NET Patient Conference:

Topic: I-131 MIBG Therapy: Results of our First 100 Cases

When: Friday, September 23rd, 2016 at 1:30PM*

SIGN UP NOW FOR THE 2016 NATIONAL NET PATIENT CONFERENCE in New Orleans, LA from September 22-24th to see Dr. Campeau and 19 other experts speak on Neuroendocrine Cancer! 

Registration is $125 per person including

  • Thursday’s Welcome Reception 
  • Breakfast, Lunch, and snacks for both Friday and Saturday
  • And keep your eyes out for some special prizes!

Registration does not include your hotel stay or travel expenses.

For more information and to buy your ticket, click here!!

*Time and Date are subject to change.